ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SWC Celadon Pharmaceuticals Plc

147.50
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:SWC London Ordinary Share Ordinary Shares
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 147.50 140.00 155.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Summerway Capital PLC Change in Accounting Reference Date (9267T)

29/11/2021 3:16pm

UK Regulatory


Celadon Pharmaceuticals (LSE:SWC)
Historical Stock Chart


From Mar 2021 to Mar 2024

Click Here for more Celadon Pharmaceuticals Charts.

TIDMSWC

RNS Number : 9267T

Summerway Capital PLC

29 November 2021

29 November 2021

Summerway Capital Plc

("Summerway" or the "Company")

Change in Accounting Reference Date

The Board of Directors of Summerway Capital Plc (AIM: SWC) today announces that it will be changing its accounting reference date and financial year end from 31 August to 31 December.

The accounting reference date change to 31 December has been made to align the Company's accounting reference date with that of Vertigrow Technologies Ltd, the proposed acquisition announced on 28 October 2021.

As a result, the Company's next financial reporting events will be as follows:

-- Publication of interim results for the 12 months to 31 August 2021, not later than 30 November 2021;

-- Publication of audited accounts for the 16 month period to 31 December 2021, not later than 30 April 2022; and

-- Publication of interim results for the 6 months ended 30 June 2022, not later than 30 September 2022.

Enquiries:

Summerway Capital Plc

   Tony Morris        020 7440 7520 
   Canaccord Genuity Limited         (Nominated Adviser and Broker) 
   Andrew Potts    020 7523 8000 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDKCBDPBDDQDB

(END) Dow Jones Newswires

November 29, 2021 10:16 ET (15:16 GMT)

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock